Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05071053
Title Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer (CARMEN-GC01)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Ramucirumab + SAR408701

Age Groups: adult | senior
Covered Countries ESP | BEL

No variant requirements are available.